<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="107769">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02143063</url>
  </required_header>
  <id_info>
    <org_study_id>14-090-2</org_study_id>
    <secondary_id>P50DA009241</secondary_id>
    <nct_id>NCT02143063</nct_id>
  </id_info>
  <brief_title>Extending Long-term Outcomes Through an Adaptive Aftercare Intervention</brief_title>
  <official_title>Extending Long-term Outcomes Through an Adaptive Aftercare Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Connecticut Health Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Connecticut Health Center</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Reinforcement interventions have pronounced effects on reducing cocaine use. This study will
      evaluate a novel approach in which reinforcement frequency varies by patient performance. To
      test efficacy, 280 patients with cocaine use disorder will be randomly assigned to: standard
      care, standard care plus traditional twice weekly reinforcement, or standard care plus
      adaptive variable interval reinforcement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">January 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>longest duration of abstinence from cocaine</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>as measured by urine toxicology reports</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Cocaine Use Disorder</condition>
  <condition>Contingency Management</condition>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>standard care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care plus traditional contingency managment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>prize contingency management on a traditional twice weekly schedule for cocaine abstinence</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care plus variable interval contingency management</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>prize contingency management on a variable interval schedule for cocaine abstinence</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>prize contingency management on a traditional twice weekly schedule for cocaine abstinence</intervention_name>
    <arm_group_label>standard care plus traditional contingency managment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>prize contingency management on a variable interval schedule for cocaine abstinence</intervention_name>
    <arm_group_label>standard care plus variable interval contingency management</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>standard care</intervention_name>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_label>standard care plus traditional contingency managment</arm_group_label>
    <arm_group_label>standard care plus variable interval contingency management</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  be age 18 years or older

          -  have a cocaine use disorder diagnosis

          -  be willing to sign informed consent and able to pass an informed consent quiz

        Exclusion Criteria:

          -  serious, uncontrolled psychiatric illness

          -  in recovery from pathological gambling

          -  do not speak English
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy Petry, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Connecticut Health Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ellen Ciesielski</last_name>
    <phone>860.679.4556</phone>
    <email>eciesielski@uchc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Regional Network of Programs, Inc.</name>
      <address>
        <city>Bridgeport</city>
        <state>Connecticut</state>
        <zip>06610</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen Ciesielski</last_name>
      <phone>860-679-4556</phone>
      <email>eciesielski@uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy M Petry, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Alcohol and Drug Recovery Centers, Inc.</name>
      <address>
        <city>Hartford</city>
        <state>Connecticut</state>
        <zip>06112</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen Ciesielski</last_name>
      <phone>860-679-4556</phone>
      <email>eciesielski@uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy M Petry, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Hospital of Central Connecticut at New Britain General</name>
      <address>
        <city>New Britain</city>
        <state>Connecticut</state>
        <zip>06050</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen Ciesielski</last_name>
      <phone>860-679-4556</phone>
      <email>eciesielski@uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy Petry, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Behavioral Health Network, Inc.</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ellen Ciesielski</last_name>
      <phone>860-679-4556</phone>
      <email>eciesielski@uchc.edu</email>
    </contact>
    <investigator>
      <last_name>Nancy M Petry, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 16, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Substance-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
